Curatis Holding AG announces CHF 3.0 million private placement

On 2026-05-22, Curatis Holding AG announced a definitive agreement for a CHF 3.0 million private placement of a convertible instrument with a strategic Swiss investor. The company said the proceeds will support clinical development work for corticorelin and related Phase III preparations, with closing anticipated the same day subject to customary conditions.